Clinical Trial Update: Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial updating the effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients with secondary hyperparathyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease Requiring Chronic Dialysis
• Hyperparathyroidism
• Left Ventricular Hypertrophy

Drugs mentioned

• Etelcalcetide (etelcalcetide)

Snippet

Sponsor: Rainer Oberbauer | Conditions: Secondary Hyperparathyroidism, Chronic Kidney Disease Requiring Chronic Dialysis | Phase 4 | Status: COMPLETED